Riskpilot← Back to searchSign inGet full accessTREKANTEN LEGESENTER ASKER AS
ASActiveOrg 925691798Knud Askers Vei 28B, 1383 AskerGeneral medical practice activities · NACE 8621Est. 20205 employees
Revenue 2025
NOK 6,1M
-2% vs 2024
EBITDA margin
5.6%
+20% vs 2024
Equity ratio
61.4%
Financial strength
Net profit 2025
NOK 218K
+37% vs 2024
| Revenue | NOK 6,1M | -2% |
| EBITDA | NOK 342K | +20% |
| Net profit | NOK 218K | +37% |
| Total assets | NOK 1,4M | -3% |
| Equity | NOK 879K | +33% |
| Employees | 5 | — |
Legal name
TREKANTEN LEGESENTER ASKER AS
Org number
925691798
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. september 2020
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å tilby kontorfellesskap for leger/ legesenter samt det som naturlig står i forbindelse med dette, herunder deltagelse i andre foretak.
Address
Knud Askers Vei 28B, 1383 Asker
Phone
+4766799080
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 272 | 5 031 | 5 687 | 6 222 | 6 115 |
| Staff expenses | −2 251 | −2 315 | −2 760 | −2 674 | −2 716 |
| EBITDA | 622 | 45 | 68 | 286 | 342 |
| Depreciation & amort. | −16 | −32 | −77 | −77 | −76 |
| EBIT | 606 | 13 | −9 | 209 | 266 |
| Net financials | 0 | 2 | 3 | 0 | 23 |
| Profit before tax | 607 | 15 | −5 | 209 | 289 |
| Tax | 131 | 3 | −1 | 49 | 71 |
| Net profit | 476 | 12 | −4 | 159 | 218 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 048 | 1 080 | 1 286 | 1 481 | 1 432 |
| Equity | 494 | 505 | 501 | 661 | 879 |
| Long-term debt | 801 | 9 | 6 | 0 | 0 |
| Short-term debt | 754 | 565 | 779 | 820 | 553 |
| Total debt | 1 555 | 574 | 784 | 820 | 553 |
EBITDA margin
5.6%
This company
15.8%
Market median
-65% vs market
20212025
Equity ratio
61.4%
This company
38.2%
Market median
+61% vs market
20212025
Return on equity
24.8%
This company
18.4%
Market median
+35% vs market
20212025
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20212025
Asset turnover
4.27×
This company
1.12×
Market median
+281% vs market
20212025
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2023 | |
| Individual | 20% | 20% | 2023 | |
| Individual | 20% | 20% | 2023 | |
| Company | 20% | 20% | 2023 | |
| Individual | 20% | 20% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TREKANTEN LEGESENTER ASKER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Astrid Jelstad | Board of Directors | 0 companies |
| Cecilie Ylvisåker Wexels | Board of Directors | 0 companies |